Researchers have found the injectable weight-loss treatment Ozempic could reduce the risk of heart attacks across the UK.
A study revealed semaglutide, a key ingredient in treatments including Wegovy and Ozempic could likely boost the cardiovascular health of millions.
UK correspondent Enda Brady says it's likely Ozempic will be routinely prescribed in the UK by the end of the decade. Â
LISTEN ABOVE
Take your Radio, Podcasts and Music with you
